Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood-CSF barrier during development in the nonhuman primate (P.hamadryas)

Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood-CSF barrier during development in the nonhuman primate (P.hamadryas)

Reprod Toxicol., 2015 · DOI: 10.1016/j.reprotox.2015.06.047 · Published: August 15, 2015

PharmacologyNeurologyGenetics

Simple Explanation

The choroid plexus (CP) acts as a barrier between blood and brain, influencing drug movement. This study examines the CP's barrier mechanisms, metabolism, and xenobiotic transporters in fetal nonhuman primates during the second half of gestation. The study found no differences in tight-junction expression, suggesting a well-formed blood-CSF barrier in the fetus. The fetal CP expresses enzymes for metabolism and transporters, indicating a significant ability to deactivate reactive molecules. The research indicates that the CP in nonhuman primates is restrictive from midgestation onwards and expresses genes associated with barrier function and transport.

Study Duration
Second half of gestation
Participants
Female baboons (Papio hamadryas) and their fetuses
Evidence Level
Not specified

Key Findings

  • 1
    There were no differences in the expression of the tight-junctions at the CP suggesting a well-formed fetal blood-CSF barrier during this period of gestation.
  • 2
    The fetal CP express many enzymes for phase I–III metabolisms as well as transporters suggesting that it can greatly influence drug disposition and has a significant machinery to deactivate reactive molecules with only minor gestational changes.
  • 3
    The study suggests that from, at least, midgestation, the CP in the nonhuman primate is restrictive and express most known genes associated with barrier function and transport.

Research Summary

This study investigated the blood-CSF barrier in nonhuman primate fetuses during the second half of gestation, focusing on tight junctions and enzymes/transporters involved in xenobiotic metabolism and transport. The findings indicate a well-developed choroid plexus barrier by mid-gestation, with functional tight junctions and enzyme/transport mechanisms for xenobiotic metabolism. The study suggests that the fetal choroid plexus has significant antioxidant activity and can influence xenobiotic and nutrient supply to the brain.

Practical Implications

Drug Development

Understanding fetal drug metabolism can aid in designing safer medications for pregnant women.

Environmental Health

Knowing how environmental toxins are handled by the fetal brain barriers informs risk assessment and prevention strategies.

Neuroprotection

Supporting antioxidant systems in the fetal choroid plexus may protect the developing brain from damage.

Study Limitations

  • 1
    Lack of comparison of gene transcription changes in the fetus with adult animals.
  • 2
    Molecular analyses of tight junctions are only indicative of barrier function and require functional tests for confirmation.
  • 3
    Uncertainty of transport direction for many transporters limits full interpretation of changes at the choroid plexus.

Your Feedback

Was this summary helpful?

Back to Pharmacology